Cytokines. Experiment 2

Cytokines. Experiment

Apodemus. Trapping, biometric data, parasites and TLR2-stimulated TNF

Apodemus. Trapping, biometric data, parasites and TLR2-stimulated TN

Q-PCR data for BALBc TLRs (Experiment 1)

Q-PCR data for BALBc TLRs (Experiment 1

Additional file 1: Figure S1. of Factors associated with Anaplasma spp. seroprevalence among dogs in the United States

Statewide Deer/Vehicle Collision Percentages in 2013. (JPG 2151 kb

Additional file 2: Figure S2. of Factors associated with Anaplasma spp. seroprevalence among dogs in the United States

Granulocytic anaplasmosis-endemic areas of the United States. Areas where granulocytic anaplasmosis is considered endemic are reflective of counties surrounding established I. scapularis and I. pacificus populations and where clinical diagnosis of granulocytic anaplasmosis or competent reservoir hosts have been reported. Counties where granulocytic anaplasmosis is considered endemic are shaded red; non-endemic counties are shaded white. (JPG 2025 kb

CD8⁺ T-Cell Activation during Acute HIV-1 Infection

<div><p>(A) Percentages of activated CD38⁺ cells (gated on whole CD8⁺ T-cells, HIV tetramer-positive CD8⁺ T-cells, or whole CD4⁺ T-cells) in donors during acute HIV-1 infection and later postacute on ART (<i>n</i> = 12); healthy donors (<i>n</i> = 11) and untreated donors with nonprogressing chronic infection (<i>n</i> = 12) are also shown.</p> <p>(B and C) CD38 and Ki67 expression on CD8⁺ T-cell subsets defined by CD45RA/CD62L (B) or CD28/CD27 (C) expression, shown in one single donor from acute to postacute (on ART) HIV-1 infection. Percentages of positive cells are shown. Means (± SEM) of CD38⁺ and Ki67⁺ CD8⁺ T-cells for ten patients are also shown; statistics concern CD38 expression.</p> <p>(D) Staining for the activation marker CD38 on CMV-, EBV-, or influenza A virus-specific CD8⁺ T-cells during acute and postacute (on ART) HIV-1 infection in a single donor. Percentages of CD38⁺ tetramer-positive CD8⁺ T-cells are shown. Data on all donors (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0020020#pbio-0020020-t001" target="_blank">Table 1</a>) are also shown.</p> <p>(E) Activation (CD38 and Ki67 staining) of CMV-specific CD8⁺ T-cells or whole CD8⁺ T-cell population during acute and postacute (on ART) HIV-1 infection in a single donor. Percentages of cells present in quadrants are shown.</p> <p>Statistics: * <i>p</i> < 0.002, ** <i>p</i> < 0.01, NS = nonsignificant, with the nonparametric Mann–Whitney test.</p></div

CD8⁺ T-Cell Differentiation and Senescence

<div><p>(A) Expression of the replicative senescence-associated marker CD57 on antigen-experienced CD8⁺ T-cell subsets. The percentage and mean fluorescence intensity for the CD57⁺ cells are shown for one single donor. Data on several donors (HIV-1-infected or healthy) are also shown (<i>n</i> = 24).</p> <p>(B) Expression of CD57 on CD8⁺ T-cells (whole population or antigen-specific) from acute to postacute (on ART) HIV-1 infection.</p> <p>(C) CD69 expression and CFSE proliferation profile for CD8⁺ T-cell subsets gated on the basis of CD57 and CD27 expression following stimulation with anti-CD3 antibodies. PBMCs were analysed for CD69 expression after 18 h and CFSE labeling after 6 d. Percentages of proliferating cells (with background subtracted) are indicated. Representative results from three experiments (one HIV-infected and two healthy donors) are shown.</p> <p>(D) Telomere length measurement by flow FISH on naïve and antigen-experienced CD8⁺ T-cell subsets FACS-sorted on the basis of CD57, CD27, CCR7, and CD45RA expression. The average length of telomeres was obtained by substracting the mean fluorescence of the background control (no probe; open histogram) from the mean fluorescence obtained from cells hybridised with the FITC-labeled telomere probe (gray histogram). Representative results from two experiments (on healthy donors) are shown.</p> <p>(E) CD57 and perforin expression in the CD8⁺ T-cell population dissected into naïve (CD27^+high, perforin-negative), antigen-experienced CD27⁺ (perforin^low), and antigen-experienced CD27⁻ perforin^low or perforin^high subsets. The percentage and mean fluorescence intensity for the CD57⁺ cells are indicated.</p> <p>(F) Representative staining for perforin and CD57 in CD8⁺ T-cells from a HIV-1-infected or a healthy donor. Percentages of cells present in the top quadrants are shown.</p> <p>(G) Representative staining for perforin and CD57 in CD4⁺ T-cells from an HIV-1-infected or a healthy donor. Percentages of cells present in the top quadrants are shown.</p></div

CD8⁺ T-Cell Differentiation and HIV-1 Disease Progression

<div><p>(A) Distribution of the CD8⁺ T-cell population in differentiated subsets (CD28⁺/CD27⁺ early, CD28⁻/CD27⁺ intermediate, and CD28⁻/CD27⁻ late) through the course of HIV-1 infection. Abbreviations: H, healthy (<i>n</i> = 15); A, acute HIV infection (<i>n</i> = 11); C, chronic HIV infection nonprogressor (no ART; <i>n</i> = 14); P, chronic HIV infection with signs of disease progression (no ART; <i>n</i> = 10). Statistics: * <i>p</i> < 0.0001 with the ANOVA test and <i>p</i> < 0.005 between each group.</p> <p>(B) Percentages of CD27⁻ CD8⁺ T-cells that are specific for HLA-B8 HIV (nef) or HLA-A2 CMV in HIV-1-infected individuals at different stages of infection. Statistics: ** <i>p</i> < 0.005 with the nonparametric Mann–Whitney test.</p> <p>(C) Inverse correlation between CD4⁺ T-cell counts and percentage of highly differentiated CD27⁻ cells in the whole CD8⁺ T-cell population of HIV-1-infected donors during chronic infection (untreated nonprogressors and progressors). The <i>p</i> value was obtained using the nonparametric Spearman rank correlation test.</p></div